These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7048877)

  • 21. [Treatment of hypertension with a fixed combination of pindolol and clopamide (VKB-105)].
    Sekso M; Vizner B; Benković K
    Lijec Vjesn; 1984; 106(11-12):512-4. PubMed ID: 6394939
    [No Abstract]   [Full Text] [Related]  

  • 22. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of several hypotensors on the working blood pressure and on the output in subjects with stage II hypertension (author's transl)].
    Chrástek J; Matousek O
    Cas Lek Cesk; 1977 Feb; 116(3):80-4. PubMed ID: 844063
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients.
    Jespersen CM; Jørgensen PH; Krogsgaard AR; Friis T
    Scand J Clin Lab Invest; 1986 Nov; 46(7):615-21. PubMed ID: 3538363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pindolol in hypertension: a double-blind trial.
    Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
    N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pindolol as an antihypertensive agent].
    Pinggera WF; Fitscha P; Stummvoll HK; Wolf A; Dorda P
    Fortschr Med; 1977 Feb; 95(5):310-14. PubMed ID: 838451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
    Nyberg G; Asplund J; Anagreus N; Aström B; Leppert J; Bergström R; Overmo J; Kullman S; Lessem J
    Lancet; 1982 Feb; 1(8268):355-8. PubMed ID: 6120347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of single-daily-dose pindolol in arterial hypertension].
    Thomas J; Pierredon M; Sankale M
    Therapie; 1978; 33(6):797-804. PubMed ID: 371062
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metolazone and pindolol in the treatment of hypertension: a double blind multicentre trial.
    Hickey N; O'Donoghue S; Guiry U; Graham I; Mulcahy R; Belton P; Carmody M; Sheridan J; Quigley P; Jackson M
    Ir Med J; 1982 Jun; 75(6):194-6. PubMed ID: 7050009
    [No Abstract]   [Full Text] [Related]  

  • 32. Methyldopa combined with prindolol in the treatment of severe hypertension.
    Seedat YK
    S Afr Med J; 1974 Aug; 48(38):1608-10. PubMed ID: 4615382
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihypertensive therapy with pindolol--comparison between 2 doses and a single dose per day].
    Jacobsson KA
    Lakartidningen; 1976 Jul; 73(28-29):2500-1. PubMed ID: 781431
    [No Abstract]   [Full Text] [Related]  

  • 35. [Double-blind cross-over study of the anti-hypertensive effectiveness of mepindolol, hydrochlorothiazide and their combination].
    Pessina AC; Casiglia E; Palatini P; Semplicini A; Hlede M; Gava R
    G Clin Med; 1981 Mar; 62(3):200-8. PubMed ID: 7018979
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
    Zdichynec B
    Z Kardiol; 1977 Sep; 66(9):508-10. PubMed ID: 335687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Viskaldix therapy in the treatment of hypertensive patients.
    Dudás M; Iványi J
    Ther Hung; 1985; 33(3):152-5. PubMed ID: 3842011
    [No Abstract]   [Full Text] [Related]  

  • 38. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive treatment with pindolol in one or two doses. A comparative trial.
    Gyntelberg F; Rasmussen K; Harvald B
    Acta Med Scand; 1978; 204(3):169-71. PubMed ID: 358760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.